ABIRATERON-ACETAT-FORMULIERUNG

European patent · EP2969227 · Deleted

Register entry

Publication number
EP2969227
Application number
EP14765788
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 17, 2014
Published
Jan 20, 2016
Granted
May 8, 2019
Deleted
Mar 31, 2020
Reason
Annual fee unpaid
IPC classes
B02C 19/00 (2006.01)
A61P 35/00 (2006.01)
A61P 13/08 (2006.01)
A61K 9/20 (2006.01)
A61K 9/14 (2006.01)
A61K 31/573 (2006.01)
A61K 31/58 (2006.01)
C07J 43/00 (2006.01)
A61K 9/16 (2006.01)
Priority
US 201361789141 P 15.03.2013
US 201361883941 P 27.09.2013
PCT application
PCT/US2014/030642 17.03.2014
PCT publication
WO2014/145813 18.09.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 21, 2020

    Deleted, fee unpaid

    Published in Swissreg on 21.10.2020

  2. Aug 14, 2019

    Owner

    Owner
    Iceutica Inc., One Crescent Drive, Suite 400, Philidelphia, Pennsylvania 19112, USA → Sun Pharma Global FZE, No.43, Block Y, SAIF Zone, P.O. Box No.122304, Sharjah, United Arab Emirates

    Published in Swissreg on 14.08.2019

  3. May 8, 2019

    Granted

    Published in Swissreg on 08.05.2019

Parties

Holder

Sun Pharma Global FZE

No.43, Block Y, SAIF Zone P.O. Box No.122304, Sharjah, AE

Inventor

BOSCH, H. William

Philidelphia, Pennsylvania 19112, US

CALLAHAN, Matt

Philidelphia, Pennsylvania 19112, US

NORRET, Marck

Philidelphia, Pennsylvania 19112, US

NEMETH, Paul

Philidelphia, Pennsylvania 19112, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.